Camfield, David
Barwon Health · Deakin University
6 papers on CoChatORCID 0000-0001-7925-2566
Most cited papers
- Verified
Acute effects of tea constituents L-theanine, caffeine, and epigallocatechin gallate on cognitive function and mood: a systematic review and meta-analysis
Camfield, D. A., Stough, C., Farrimond, J., & Scholey, A. B. (2014) · Nutrition Reviews
Tea Polyphenols and EffectsCoffee research and impacts
Cited by 155
- Verified
N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review
Oliver, G., Dean, O., Camfield, D., Blair-West, S., Ng, C., Berk, M., & Sarris, J. (2015) · Clinical Psychopharmacology and Neuroscience
Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 96
- Verified
Complementary medicine, self-help, and lifestyle interventions for Obsessive Compulsive Disorder (OCD) and the OCD spectrum: A systematic review
Sarris, J., Camfield, D., & Berk, M. (2012) · Journal of Affective Disorders
Obsessive-Compulsive Spectrum DisordersComplementary and Alternative Medicine Studies
Cited by 59
- Verified
Examining brain-cognition effects of ginkgo biloba extract: Brain activation in the left temporal and left prefrontal cortex in an object working memory task
Silberstein, R. B., Pipingas, A., Song, J., Camfield, D. A., Nathan, P. J., & Stough, C. (2011) · Evidence-based Complementary and Alternative Medicine
Ginkgo biloba and Cashew ApplicationsMedicinal Plants and Neuroprotection
Cited by 36
- Verified
The effect of Sailuotong (SLT) on neurocognitive and cardiovascular function in healthy adults: a randomised, double-blind, placebo controlled crossover pilot trial
Steiner, G. Z., Yeung, A., Liu, J.-X., Camfield, D. A., Blasio, F. M. D., Pipingas, A., Scholey, A. B., Stough, C., & Chang, D. H. (2015) · BMC Complementary and Alternative Medicine
Medicinal Plants and NeuroprotectionMedicinal Plant Extracts Effects
Cited by 36
- Verified
N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial
Sarris, J., Byrne, G., Castle, D., Bousman, C., Oliver, G., Cribb, L., Blair-West, S., Brakoulias, V., Camfield, D., Ee, C., et al. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 19
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free